BRIEF-Bristol-Myers Squibb says Health Canada approved Daklinza in combination with Sofosbuvir
May 24 (Reuters) - Bristol-myers Squibb Co
* Myers squibb announces health canada's approval of daklinza in combination with sofosbuvir
* Says health canada's approval of daklinza in treatment of chronic hepatitis c in adult patients Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.